Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
Clinical trial NCT00453167 · COMPLETED
Trial details
- NCT number
- NCT00453167
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2009-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.